Optical coherence tomography angiography is finding new uses in glaucoma, as it can depict loss of blood vessels around the optic nerve and distinguish vascular layers.
News
Advertisement
A study of patients undergoing corneal crosslinking (CXL) for keratoconus suggests gene expression and tear inflammatory profile may be used as biomarkers to predict CXL outcomes.
Advertisement
In a study including data from 67 eyes, the majority of keratoconus indices measured by two commercially available Scheimpflug devices did not effectively differentiate normal high astigmatism from subclinical keratoconus.
Treatment should focus on the underlying etiology behind these processes
Topical cenegermin has been approved by the FDA for the treatment of moderate-to-severe neurotrophic keratitis (NK), ushering in a breakthrough of management.
“The only difference between death and taxes is that death doesn’t get worse every time Congress meets.” - Will Rogers
Advertisement
Read the latest Optic Relief from OT cartoonist Jon Carter.
Visual screenings and communication are the most important components when it comes to pediatric ophthalmology, says Dr. Silverstein.
Advertisement
Advertisement
Trending on Ophthalmology Times - Clinical Insights for Eye Specialists
1
FDA clears BVI’s FineVision HP trifocal IOL for the US market
2
Treating myopia today: US-focused treatments, challenges, and global insights
3
US FDA awards Epion Therapeutics EpiSmart cross-linking system Fast Track designation
4
Abeona Therapeutics’ ABO-503 chosen for FDA's Rare Disease Endpoint Advancement Pilot Program
5
.png "Optometry Times"){kind=logo}
